Literature DB >> 17660215

Outcomes following prolonged preterm premature rupture of the membranes.

N J Everest1, S E Jacobs, P G Davis, L Begg, S Rogerson.   

Abstract

OBJECTIVE: Rupture of the membranes in the second trimester is reported to be associated with high rates of pregnancy loss, neonatal mortality and morbidity. This article describes the outcomes of liveborn infants delivered following a prolonged period of membrane rupture occurring before 24 weeks' gestation. PATIENTS AND
SETTING: Over a 5-year period, consecutive pregnancies complicated by spontaneous rupture of the membranes before 24 weeks' gestation were identified. Evaluation of short-term outcomes before discharge of liveborn infants delivered, in a tertiary referral centre, following prolonged rupture of membranes of duration greater than 2 weeks.
RESULTS: Of 98 pregnancies identified with rupture of the membranes before 24 weeks' gestation, 40 (41%) women progressed to deliver a liveborn infant following a latent period of at least 14 days. Although most liveborn infants required neonatal intensive care including mechanical ventilation (n = 38; 78%), the survival rate to hospital discharge was 70% (n = 28). Airleak occurred in 7 (25%) survivors and 8 (67%) deaths. Among the survivors, 12 (43%) required supplemental oxygen at 36 weeks' postmenstrual age and no infant had grade 3 or 4 intraventricular haemorrhage. One infant had a postmortem diagnosis of pulmonary hypoplasia and nine others had clinical features consistent with this diagnosis. Low liquor volume was not uniformly associated with a poor outcome.
CONCLUSION: With full contemporary neonatal intensive care, the outcome for liveborn infants in the present cohort delivered following membrane rupture occurring before 24 weeks' gestation, of at least 14 days duration, was better than previously reported.

Entities:  

Mesh:

Year:  2007        PMID: 17660215     DOI: 10.1136/adc.2007.118711

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  8 in total

1.  Mid-childhood outcomes after pre-viable preterm premature rupture of membranes.

Authors:  M H Bentsen; E Satrell; H Reigstad; S L Johnsen; M Vollsæter; O D Røksund; G Greve; A Berg; T Markestad; T Halvorsen
Journal:  J Perinatol       Date:  2017-06-29       Impact factor: 2.521

2.  Impact of duration of rupture of membranes on outcomes of premature infants.

Authors:  M W Walker; A H Picklesimer; R H Clark; A R Spitzer; T J Garite
Journal:  J Perinatol       Date:  2014-04-24       Impact factor: 2.521

3.  Labor induction in term nulliparous women with premature rupture of membranes: oxytocin versus dinoprostone.

Authors:  Nur Gozde Kulhan; Mehmet Kulhan
Journal:  Arch Med Sci       Date:  2018-06-01       Impact factor: 3.318

4.  Use of sildenafil in an infant with persistent pulmonary hypertension secondary to lung and renal hypoplasia - a case report.

Authors:  Karen Lavie-Nevo; Kevin C Harris; Joseph Y Ting
Journal:  BMC Pediatr       Date:  2019-11-06       Impact factor: 2.125

5.  Neonatal Outcomes according to the Latent Period from Membrane Rupture to Delivery among Extremely Preterm Infants Exposed to Preterm Premature Rupture of Membrane: a Nationwide Cohort Study.

Authors:  Jae Hyun Park; Jin Gon Bae; Yun Sil Chang
Journal:  J Korean Med Sci       Date:  2021-04-12       Impact factor: 2.153

Review 6.  Economical Analysis of Different Clinical Approaches in Pre-Viability Amniorrhexis-A Case Series.

Authors:  Samuel Engemise; Fiona Thompson; William Davies
Journal:  J Clin Med       Date:  2014-01-09       Impact factor: 4.241

7.  Preterm infant outcomes in relation to the gestational age of onset and duration of prelabour rupture of membranes: a retrospective cohort study.

Authors:  Pramod Pharande; Abdel-Latif Mohamed; Barbara Bajuk; Kei Lui; Srinivas Bolisetty
Journal:  BMJ Paediatr Open       Date:  2017-12-29

8.  A Novel Approach to Serial Amnioinfusion in a Case of Premature Rupture of Membranes Near the Limit of Viability.

Authors:  Katherine Kohari; Krista Mehlhaff; Audrey Merriam; Sonya Abdel-Razeq; Olga Grechukhina; Daisy Leon-Martinez; Mert Ozan Bahtiyar
Journal:  AJP Rep       Date:  2018-09-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.